Divi's Laboratories Ltd. Conference Calls and Earnings Call Transcripts

17 Aug 2022

6544.50

-1.27%

Earnings Call

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

We hereby submit the transcript of the earnings conference call for the quarter ended June 30, 2022, held on August 12, 2022 at 14.00 Hrs IST. The transcript is also available on the website of the Company i.e. www.divislabs.com, under Investors Relations section. This is for your information and records.

pdf

Divi's Laboratories Ltd.

12 Aug 2022

6544.50

-1.27%

Earnings Call

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and further to our intimation letter dated July 29, 2022, we hereby inform that the audio recording of the earnings call for the quarter ended June 30, 2022, held on August 12, 2022 at 14.00 Hrs IST have been uploaded on the Company's website at the following weblink: https://www.divislabs.com/wp-content/uploads/2022/08/EarningsCallAudioQ1FY23.mp3 This is for your information and records.

pdf

Divi's Laboratories Ltd.

26 May 2022

6544.50

-1.27%

Earnings Call

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

We are herewith enclosing copy of the transcript of the Company's earnings conference call for Q4 and full year FY22, held on May 23, 2022. This transcript is also uploaded on our website www.divislabs.com under Investor Relations section. This is for your information and records.

pdf

Divi's Laboratories Ltd.

23 May 2022

6544.50

-1.27%

Earnings Call

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and further to our intimation letter dated May 16, 2022, we hereby inform that the audio recording of the earnings call for the quarter and financial year ended March 31, 2022, held on May 23, 2022, at 14.00 Hrs IST have been uploaded on our website at the following weblink: https://www.divislabs.com/wp-content/uploads/2022/05/DIV0320220523141281.mp3 This is for your information and records.

pdf

Divi's Laboratories Ltd.

23 May 2022

6544.50

-1.27%

Earnings Call for Q4FY22 of Divi's Laboratories

Conference Call with Divi's Laboratories Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.

Divi's Laboratories Ltd.

11 Feb 2022

6544.50

-1.27%

Earnings Call for Q3FY22 of Divi's Laboratories

Conference Call with Divi's Laboratories Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.

audio

Divi's Laboratories Ltd.

07 Nov 2021

6544.50

-1.27%

Earnings Call for Q2FY22 of Divi's Laboratories

Conference Call with Divi's Laboratories Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.

Divi's Laboratories Ltd.

07 Aug 2021, 04:19PM

6544.50

-1.27%

Earnings Call for Q1FY22 of Divi's Laboratories

Conference Call with Divi's Laboratories Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript.

Divi's Laboratories Ltd.

29 May 2021

6544.50

-1.27%

Earnings Call for Q4FY21 of Divi's Laboratories

Conference Call with Divi's Laboratories Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript.

Divi's Laboratories Ltd.

06 Feb 2021, 10:48PM

6544.50

-1.27%

Earnings Call for Q3FY21 of Divi's Laboratories

Conference Call with Divi's Laboratories Management and Analysts on Q3FY21 Performance and Outlook. Listen to the full earnings transcript.

Divi's Laboratories Ltd. Conference Calls and Earnings Call Transcripts